Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Clot Chronicles: Thrombosis in Hospitalized Pediatric Patients with COVID-19 and MIS-C

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Research and Practice in Thrombosis and Haemostasis

Frontiers Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review

MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network

Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium - eClinicalMedicine

Frontiers The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C)

Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection

Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C

COVID-19 hospitalizations among children likely overcounted, researchers find, News Center

MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network